Mendota Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-487
Closed -$70.4K 244
2024
Q4
$70.4K Buy
487
+40
+9% +$6.2K 0.05% 124
2024
Q3
$72.4K Buy
447
+5
+1% +$797 0.03% 145
2024
Q2
$64.6K Hold
442
0.03% 152
2024
Q1
$69.9K Hold
442
0.04% 159
2023
Q4
$69.3K Hold
442
0.05% 175
2023
Q3
$68.8K Sell
442
-251
-36% -$41.4K 0.07% 119
2023
Q2
$115K Buy
693
+400
+137% +$64.6K 0.13% 78
2023
Q1
$51.9K Sell
293
-424
-59% -$68.5K 0.05% 139
2022
Q4
$127K Buy
+717
New +$124K 0.16% 72

Other funds holding JNJ

Mendota Financial Group's JNJ Position: Q1 2025 in Review

Mendota Financial Group sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 487 shares — an estimated $70.4K sold.

Mendota Financial Group first reported a position in JNJ in Q4 2022 and held it in 9 quarters. The position peaked at $127K in Q4 2022. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Mendota Financial Group reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
  • Mendota Financial Group sold 487 Johnson & Johnson shares in Q1 2025, an estimated $70.4K.
  • Mendota Financial Group first reported a position in Johnson & Johnson in Q4 2022 and held it in 9 quarters.
  • Mendota Financial Group's Johnson & Johnson position peaked at $127K in Q4 2022.
  • 4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Mendota Financial Group's 13F filing for Q1 2025, filed 22 Apr 2025.